These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 7548800

  • 21. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
    Hsia HC, Lin HC, Lee FY, Tsai YT, Lee SD, Meng HC, Chao Y, Wang SS, Lo KJ.
    J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
    [Abstract] [Full Text] [Related]

  • 22. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [Abstract] [Full Text] [Related]

  • 23. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
    Afdhal N, Everson GT, Calleja JL, McCaughan GW, Bosch J, Brainard DM, McHutchison JG, De-Oertel S, An D, Charlton M, Reddy KR, Asselah T, Gane E, Curry MP, Forns X.
    J Viral Hepat; 2017 Oct; 24(10):823-831. PubMed ID: 28295923
    [Abstract] [Full Text] [Related]

  • 24. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B.
    Gastroenterol Hepatol; 2000 Oct; 23(6):275-81. PubMed ID: 15324622
    [Abstract] [Full Text] [Related]

  • 25. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.
    Triantos CK, Nikolopoulou V, Burroughs AK.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):943-52. PubMed ID: 18627364
    [Abstract] [Full Text] [Related]

  • 26. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U, Bellis L, Puoti C, Burroughs AK.
    Eur J Intern Med; 2011 Feb 15; 22(1):5-7. PubMed ID: 21238884
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J, Kravetz D, Rodes J.
    Gastroenterology; 1981 Mar 15; 80(3):518-25. PubMed ID: 6108897
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Strategy for diagnosis and precise treatment of portal hypertension with hepatic venous pressure gradient: a dream or a reality?].
    Li Y, Li P, Zhang YN, Ding HG.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):254-258. PubMed ID: 29996334
    [Abstract] [Full Text] [Related]

  • 33. Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.
    Fukuda T, Narahara Y, Kanazawa H, Matsushita Y, Kidokoro H, Itokawa N, Kondo C, Atsukawa M, Nakatsuka K, Sakamoto C.
    J Gastroenterol Hepatol; 2014 Feb 20; 29(2):325-9. PubMed ID: 24033356
    [Abstract] [Full Text] [Related]

  • 34. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, Lee SD, Lo KJ.
    J Hepatol; 1990 May 01; 10(3):370-4. PubMed ID: 2114437
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.